The initiative aims to increase biomarker testing rates in communities most impacted by lung cancer disparities. A pilot study evaluated neoadjuvant platinum, pemetrexed, and nivolumab followed by pleurectomy/decortication. Nearly 80% of patients enrolled had epithelioid histology and 65% had an ECOG performance status of 1. Researchers evaluated the combination in an effort to “further enhance the immunogenicity" of the vaccine. Occupational asbestos exposure leads to shorter survival in patients with malignant mesothelioma. Guideline-concordant therapy remains underused in most mesothelioma patients. A complete residential history should be reviewed following a mesothelioma diagnosis. Radiation therapy with HT is safe and effective in patients with malignant pleural mesothelioma. Analyzing the exhaled breath of patients with mesothelioma shows tremendous potential as a screening tool. A simple blood draw could help predict survival outcomes in patients with malignant pleural mesothelioma. A study assessed the impact of immunotherapy on OS in patients with malignant pleural mesothelioma. Adoptive cell therapy with autologous TILs was studied to determine its viability as a treatment option for mesothelioma. Asbestos exposure led to a higher incidence of asbestos-related lung cancers in naval personnel. BAP1 immunohistochemistry and p16 (CDKN2A) deletion contribute to providing a definitive diagnosis of mesothelioma. Men and women living with mesothelioma may share similar experiences but have different concerns that nurses and other ... A qualitative study took a closer look at the experiences of military veterans in the UK living with mesothelioma. The Food and Drug Administration (FDA) has approved NovoTTF-100L System (Novocure) in conjunction with pemetrexed plus ... A phase I study presented at the American Association of Clinical Research Annual Meeting showed that chimeric antigen ...